Table of Contents
38 trillion bacteria live in your gut — yet most microbiome tests can only identify them at the genus level, missing the strains that actually matter. For millions living with IBS, IBD, and chronic gut conditions, that means treatment is still guided by incomplete data.
Intus Bio's Titan-1 platform delivers strain-level microbiome resolution by combining long-read sequencing with AI — and it's already in patients' hands. GutID, launched in partnership with PacBio, is the first at-home gut health test powered by HiFi sequencing, giving consumers and clinicians a level of detail that was previously confined to research labs.
At JPM 2026, Onyx sat down with CEO Paul Denslow to find out more.
I hope you enjoy watching!
Yours sincerely,
Dr. Adil Ali
Comments